137 related articles for article (PubMed ID: 1689784)
1. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
Hudson RW; Wherrett D
J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nuclear 5 alpha-reductase activities in the stromal and epithelial fractions of human prostatic tissue.
Hudson RW
J Steroid Biochem; 1987 Mar; 26(3):349-53. PubMed ID: 2438480
[TBL] [Abstract][Full Text] [Related]
3. Studies of the nuclear 5 alpha-reductase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant, and normal tissues.
Hudson RW; Moffitt PM; Owens WA
Can J Biochem Cell Biol; 1983 Jul; 61(7):750-5. PubMed ID: 6194868
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
Weisser H; Krieg M
Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
6. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
7. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
Bard DR; Lasnitzki I
J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
[TBL] [Abstract][Full Text] [Related]
8. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
[No Abstract] [Full Text] [Related]
9. Androgen metabolism in the human prostatic cancer cell line LNCaP.
Negri-Cesi P; Motta M
J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):89-96. PubMed ID: 7947355
[TBL] [Abstract][Full Text] [Related]
10. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland.
Leake A; Chisholm GD; Habib FK
J Steroid Biochem; 1984 Feb; 20(2):651-5. PubMed ID: 6200703
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 3 alpha-hydroxysteroid dehydrogenase activities in the microsomal fractions of hyperplastic, malignant and normal human prostatic tissues.
Hudson RW
J Steroid Biochem; 1984 Apr; 20(4A):829-33. PubMed ID: 6200705
[TBL] [Abstract][Full Text] [Related]
12. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
Perel E; Killinger DW
J Steroid Biochem; 1983 Aug; 19(2):1135-9. PubMed ID: 6193342
[TBL] [Abstract][Full Text] [Related]
13. Altered androgen metabolism in metastatic prostate cancer.
Kliman B; Prout GR; Maclaughlin RA; Daly JJ; Griffin PP
J Urol; 1978 May; 119(5):623-6. PubMed ID: 77915
[TBL] [Abstract][Full Text] [Related]
14. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
[TBL] [Abstract][Full Text] [Related]
15. Altered androgen metabolism in carcinoma of the prostate.
Ghanadian R; Masters JR; Smith CB
Eur Urol; 1981; 7(3):169-70. PubMed ID: 6162644
[TBL] [Abstract][Full Text] [Related]
16. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
Habib FK; Tesdale AL; Chisholm GD; Busuttil A
J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
[TBL] [Abstract][Full Text] [Related]
17. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
Isaacs JT; Brendler CB; Walsh PC
J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of androgens in human hyperplastic prostate: evidence for a differential localization of the enzymes involved in the metabolism.
Abalain JH; Quemener E; Carre JL; Simon B; Amet Y; Mangin P; Floch HH
J Steroid Biochem; 1989; 34(1-6):467-71. PubMed ID: 2483221
[TBL] [Abstract][Full Text] [Related]
19. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
20. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
